我国生物制品通用名命名原则的修订

发布时间：2019-05-27 00:18

【摘要】：对我国生物制品通用名命名原则进行了立题研究,旨在建立和完善我国生物制品通用名称命名原则。通过分析我国生物制品通用名现状、存在的问题及新型生物药发展趋势,研究比较了国际上具有主导性的药品通用名命名体系,并参照世界卫生组织国际非专利名称(WHO INN)命名原则,在中文语言识别的基础上,对我国生物制品通用名称命名原则提出了具体的增修订意见。
[Abstract]:The general name naming principle of biological products in China is studied in order to establish and perfect the general name naming principle of biological products in China. Based on the analysis of the present situation of general names of biological products in China, the existing problems and the development trend of new biological drugs, the universal name naming system of drugs, which is dominant in the world, is studied and compared. Referring to the (WHO INN) naming principle of the World Health Organization (WHO), on the basis of Chinese language recognition, this paper puts forward some suggestions on the general name naming principle of biological products in China.
【作者单位】：国家药典委员会;
【基金】：国家“重大新药创制”资助项目(2015ZX09501008-003)
【分类号】：R95

【相似文献】